43 related articles for article (PubMed ID: 30414907)
1. TWEAK/Fn14 Interaction Confers Aggressive Properties to Cutaneous Squamous Cell Carcinoma.
Hu G; Liang L; Liu Y; Liu J; Tan X; Xu M; Peng L; Zhai S; Li Q; Chu Z; Zeng W; Xia Y
J Invest Dermatol; 2019 Apr; 139(4):796-806. PubMed ID: 30414907
[TBL] [Abstract][Full Text] [Related]
2. TWEAK activation of the non-canonical NF-κB signaling pathway differentially regulates melanoma and prostate cancer cell invasion.
Armstrong CL; Galisteo R; Brown SA; Winkles JA
Oncotarget; 2016 Dec; 7(49):81474-81492. PubMed ID: 27821799
[TBL] [Abstract][Full Text] [Related]
3. TWEAK/Fn14 Activation Participates in Skin Inflammation.
Liu Q; Xiao S; Xia Y
Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
[TBL] [Abstract][Full Text] [Related]
4. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract][Full Text] [Related]
5. Editorial Note: Cutaneous Squamous Cell Carcinoma (SCC) and the DNA Damage Response: pATM Expression Patterns in Pre-Malignant and Malignant Keratinocyte Skin Lesions.
PLOS ONE Editors
PLoS One; 2024; 19(5):e0303120. PubMed ID: 38696417
[No Abstract] [Full Text] [Related]
6. Genetically predicted TWEAK mediates the association between lipidome and Keratinocyte Carcinomas.
Lei H; Chen X; Bai R; Wang Q; Xian N; Zhao X; Zhou X; Zheng Y; Wang G
Skin Res Technol; 2024 Jul; 30(7):e13781. PubMed ID: 38932454
[TBL] [Abstract][Full Text] [Related]
7. Plasma Treatment Limits Cutaneous Squamous Cell Carcinoma Development In Vitro and In Vivo.
Pasqual-Melo G; Nascimento T; Sanches LJ; Blegniski FP; Bianchi JK; Sagwal SK; Berner J; Schmidt A; Emmert S; Weltmann KD; von Woedtke T; Gandhirajan RK; Cecchini AL; Bekeschus S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708225
[TBL] [Abstract][Full Text] [Related]
8. TWEAK/Fn14 axis is an important player in fibrosis.
Zhang Y; Zeng W; Xia Y
J Cell Physiol; 2021 May; 236(5):3304-3316. PubMed ID: 33000480
[TBL] [Abstract][Full Text] [Related]
9. TWEAK/Fn14 axis in respiratory diseases.
Wang M; Xie Z; Xu J; Feng Z
Clin Chim Acta; 2020 Oct; 509():139-148. PubMed ID: 32526219
[TBL] [Abstract][Full Text] [Related]
10. Activation of fibroblast growth factor-inducible 14 in the early phase of childhood IgA nephropathy.
Tezuka Y; Eguchi-Ishimae M; Ozaki E; Ito T; Ishii E; Eguchi M
PLoS One; 2021; 16(10):e0258090. PubMed ID: 34597335
[TBL] [Abstract][Full Text] [Related]
11. Elevated fibroblast growth factor-inducible 14 expression transforms proneural-like gliomas into more aggressive and lethal brain cancer.
Connolly NP; Galisteo R; Xu S; Bar EE; Peng S; Tran NL; Ames HM; Kim AJ; Woodworth GF; Winkles JA
Glia; 2021 Sep; 69(9):2199-2214. PubMed ID: 33991013
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of TNFRSF12A in thyroid gland cancer predicts poor prognosis: A study based on TCGA data.
Wu ZH; Niu X; Wu GH; Cheng Q
Medicine (Baltimore); 2020 Aug; 99(34):e21882. PubMed ID: 32846846
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis.
Yun QS; Bao YX; Jiang JB; Guo Q
Pharmacol Rep; 2024 Apr; 76(2):263-272. PubMed ID: 38472637
[TBL] [Abstract][Full Text] [Related]
14. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy.
Zaitseva O; Hoffmann A; Otto C; Wajant H
Front Pharmacol; 2022; 13():935086. PubMed ID: 36339601
[TBL] [Abstract][Full Text] [Related]
15. Airway basal cells show regionally distinct potential to undergo metaplastic differentiation.
Zhou Y; Yang Y; Guo L; Qian J; Ge J; Sinner D; Ding H; Califano A; Cardoso WV
Elife; 2022 Sep; 11():. PubMed ID: 36178196
[TBL] [Abstract][Full Text] [Related]
16. TWEAK Promotes the Proliferation of Squamous Cell Carcinoma Cells Through Activating cIAP1 Signals.
Liang L; Cheng C; Hu G; Wang X; Liu J; Yan Z; Zeng W; Xia Y
Front Oncol; 2020; 10():439. PubMed ID: 32351884
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-like weak inducer of apoptosis expression in healthy oral mucosa, oral dysplasia and oral squamous cell carcinoma.
Acharya S; Prabhu P; Patil V; Acharya AB; Desai A; Nikhil K
J Oral Maxillofac Pathol; 2019; 23(3):369-377. PubMed ID: 31942116
[TBL] [Abstract][Full Text] [Related]
18. Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.
Wang X; Cheng D; Hu G; Liang L; Tan F; Xiao T; Xiao S; Xia Y
Mediators Inflamm; 2019; 2019():2945083. PubMed ID: 31885495
[TBL] [Abstract][Full Text] [Related]
19. Experimental atopic dermatitis is dependent on the TWEAK/Fn14 signaling pathway.
Liu Q; Wang H; Wang X; Lu M; Tan X; Peng L; Tan F; Xiao T; Xiao S; Xia Y
Clin Exp Immunol; 2020 Jan; 199(1):56-67. PubMed ID: 31515807
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
